News · Vaccines
595 stories
Aug 12, 26STAT+: Inside a $7 billion Silicon Valley startup’s mad dash to automate the business of health care
Aug 12, 26STAT+: Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say
Aug 11, 26STAT+: Trump is counting on the health care industry to remake vaccines. It’s pushing back instead
Aug 11, 26Opinion: Trump says his executive order should restore trust in vaccines. It does the exact opposite
Aug 11, 26After tasting IPO success, Hemab’s CEO seeks ‘flavor of a multi-product coagulation company’
Aug 7, 26Opinion: I was in my office when bullets hit the CDC. A year later, the agency remains under attack